Mo Zhou - Publications

Navigating the landscape of EGFR TKI resistance in EGFR-mutant NSCLC - mechanisms and evolving treatment approaches.

Journal: Nature reviews. Clinical oncology

Published: October 15, 2025

Comparative analysis of ctDNA monitoring strategies in advanced NSCLC with MET exon 14 skipping mutations treated with ensartinib.

Journal: NPJ precision oncology

Published: August 29, 2025

Efficient Inverted Blue Perovskite Light-Emitting Diodes Based on Bulk Crystal-Splitting Fabricated FAPbBrxCl3-x Nanocrystal Films.

Journal: Small methods

Published: August 18, 2025

Bimodal onset and pan-cancer uniformity of immune-mediated liver injury: a retrospective cohort study.

Journal: Frontiers in immunology

Published: April 15, 2025

Predicting the Cell-level PD-L1 Expression Status from H&E-stained Histopathological Slide.

Journal: Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference

Published: March 05, 2025

Precise diagnosis of small invasive pulmonary nodules driven by single-cell immune signatures in peripheral blood.

Journal: Nature communications

Published: March 01, 2025

Ensartinib for advanced or metastatic non-small-cell lung cancer with MET exon 14 skipping mutations (EMBRACE): a multi-center, single-arm, phase 2 trial.

Journal: EClinicalMedicine

Published: October 19, 2024

Targeting MET in NSCLC: An Ever-Expanding Territory.

Journal: JTO clinical and research reports

Published: September 02, 2023